Pesquisas alternativas:
cancer could » cancer should (Expandir a Pesquisa)
benign nevus » benign nevi (Expandir a Pesquisa), benign neck (Expandir a Pesquisa), benign nerve (Expandir a Pesquisa)
bento curve » benzoin curve (Expandir a Pesquisa), bento duarte (Expandir a Pesquisa), bento chaves (Expandir a Pesquisa)
nevus based » ivus based (Expandir a Pesquisa), nevus case (Expandir a Pesquisa), eus based (Expandir a Pesquisa)
ii benign » i benign (Expandir a Pesquisa), _ benign (Expandir a Pesquisa), a benign (Expandir a Pesquisa)
j cancer » j canter (Expandir a Pesquisa), j cantero (Expandir a Pesquisa), j candel (Expandir a Pesquisa)
based dc » based de (Expandir a Pesquisa), based d (Expandir a Pesquisa)
could e » could _ (Expandir a Pesquisa), could a (Expandir a Pesquisa), could 1 (Expandir a Pesquisa)
j bento » j benito (Expandir a Pesquisa), j benton (Expandir a Pesquisa), j benson (Expandir a Pesquisa)
e dis » e dos (Expandir a Pesquisa), e das (Expandir a Pesquisa), e des (Expandir a Pesquisa)
cancer could » cancer should (Expandir a Pesquisa)
benign nevus » benign nevi (Expandir a Pesquisa), benign neck (Expandir a Pesquisa), benign nerve (Expandir a Pesquisa)
bento curve » benzoin curve (Expandir a Pesquisa), bento duarte (Expandir a Pesquisa), bento chaves (Expandir a Pesquisa)
nevus based » ivus based (Expandir a Pesquisa), nevus case (Expandir a Pesquisa), eus based (Expandir a Pesquisa)
ii benign » i benign (Expandir a Pesquisa), _ benign (Expandir a Pesquisa), a benign (Expandir a Pesquisa)
j cancer » j canter (Expandir a Pesquisa), j cantero (Expandir a Pesquisa), j candel (Expandir a Pesquisa)
based dc » based de (Expandir a Pesquisa), based d (Expandir a Pesquisa)
could e » could _ (Expandir a Pesquisa), could a (Expandir a Pesquisa), could 1 (Expandir a Pesquisa)
j bento » j benito (Expandir a Pesquisa), j benton (Expandir a Pesquisa), j benson (Expandir a Pesquisa)
e dis » e dos (Expandir a Pesquisa), e das (Expandir a Pesquisa), e des (Expandir a Pesquisa)
1
Por Alexidis, P., Guo, W., Bekelman, J. E., Vapiwala, N., Gabriel, P. E., Christodouleas, J. P.
Publicado no Prostate Cancer Prostatic Dis (2018)
“...-escalation. METHODS: We performed analyses on pT2-3, N0, M0 prostate cancer patients who received PORT after...”Publicado no Prostate Cancer Prostatic Dis (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Diessner, J, Bruttel, V, Stein, R G, Horn, E, Häusler, S F M, Dietl, J, Hönig, A, Wischhusen, J
Publicado em 2014
“... with aggressive HER2-positive breast cancer. However, about 70% of all treated patients will experience relapse...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“... of transformation in both breast cancer and melanoma cells. Overexpression of TBX2 has also been linked to drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“... be demonstrated by computed tomographic (CT) scanning. These young patients have a variety of cancers, many...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Suntravat, Montamas, Barret, Henriquez S, Jurica, Cameron A, Lucena, Sara E, Perez, John C, Sánchez, Elda E
Publicado no J Venom Res (2015)
“..., it is suggested that r-Cam-dis could be inhibiting adhesion of pancreatic cancer cell lines through integrins α(2...”Publicado no J Venom Res (2015)
Obter o texto integral
Obter o texto integral
Artigo
6
“... and PI(4,5)P(2), without affecting receptor activation. Only knockdown of PI4KIIα inhibited EGF...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Serie, Daniel J., Crook, Julia E., Necela, Brian M., Axenfeld, Bianca C., Dockter, Travis J., Colon-Otero, Gerardo, Perez, Edith A., Thompson, E. Aubrey, Norton, Nadine
Publicado no J Cardiovasc Dev Dis (2017)
“...2+ breast cancer. In mouse models, doxorubicin is known to cause cardiomyopathy and conditional...”Publicado no J Cardiovasc Dev Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Kang, Y, Nian, H, Rajendran, P, Kim, E, Dashwood, W M, Pinto, J T, Boardman, L A, Thibodeau, S N, Limburg, P J, Löhr, C V, Bisson, W H, Williams, D E, Ho, E, Dashwood, R H
Publicado no Cell Death Dis (2014)
“... exhibit resistance mechanisms linked to anti-apoptotic Bcl-2 functions, such as BH3-only protein silencing...”Publicado no Cell Death Dis (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
10
Por Colin, D J, Limagne, E, Ragot, K, Lizard, G, Ghiringhelli, F, Solary, É, Chauffert, B, Latruffe, N, Delmas, D
Publicado no Cell Death Dis (2014)
“...In spite of the novel strategies to treat colon cancer, mortality rates associated...”Publicado no Cell Death Dis (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Polanski, R, Vincent, J, Polanska, U M, Petreus, T, Tang, E K Y
Publicado no Cell Death Dis (2015)
“...The discovery of cancer cell-selective tumour necrosis factor-related apoptosis inducing ligand...”Publicado no Cell Death Dis (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por van Heerde, M. J., Biermann, K., Zondervan, P. E., Kazemier, G., van Eijck, C. H. J., Pek, C., Kuipers, E. J., van Buuren, H. R.
Publicado em 2012
“.... The prevalence of benign disease was 8.4 %, overall prevalence of AIP was 2.6 %. Based on preoperative index...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Zhou, J, Ning, Z, Wang, B, Yun, E-J, Zhang, T, Pong, R-C, Fazli, L, Gleave, M, Zeng, J, Fan, J, Wang, X, Li, L, Hsieh, J-T, He, D, Wu, K
Publicado no Cell Death Dis (2015)
“... prostate cancer (PCa). Previously, we reported that DAB2IP modulated androgen receptor activation...”Publicado no Cell Death Dis (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Valenzano, M. C., Rybakovsky, E., Chen, V., Leroy, K., Lander, J., Richardson, E., Yalamanchili, S., McShane, S., Mathew, A., Mayilvaganan, B., Connor, L., Urbas, R., Huntington, W., Corcoran, A., Trembeth, S., McDonnell, E., Wong, P., Newman, G., Mercogliano, G., Zitin, M., Etemad, B., Thornton, J., Daum, G., Raines, J., Kossenkov, A., Fong, L. Y., Mullin, J. M.
Publicado no Dig Dis Sci (2020)
“...BACKGROUND: Chemopreventive effects of zinc for esophageal cancer have been well documented...”Publicado no Dig Dis Sci (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Joseph, J V, Conroy, S, Tomar, T, Eggens-Meijer, E, Bhat, K, Copray, S, Walenkamp, A M E, Boddeke, E, Balasubramanyian, V, Wagemakers, M, den Dunnen, W F A, Kruyt, F A E
Publicado no Cell Death Dis (2014)
“... high levels of pSMAD2 and ZEB1 that could not be suppressed by inhibition of TGF-β signaling...”Publicado no Cell Death Dis (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Chen, Y-L, Wang, S-Y, Liu, R-S, Wang, H-E, Chen, J-C, Chiou, S-H, Chang, C A, Lin, L-T, Tan, D T W, Lee, Y-J
Publicado em 2012
“... for fluorescence-based and radionuclide-based imaging of tumor growth in small animals, respectively. Iodine-123...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Hannon, Peggy A., Maxwell, Annette E., Escoffery, Cam, Vu, Thuy, Kohn, Marlana J., Gressard, Lindsay, Dillon-Sumner, Laurel, Mason, Caitlin, DeGroff, Amy
Publicado no Prev Chronic Dis (2019)
“...-based interventions (EBIs) to increase CRC screening could save many lives. The Colorectal Cancer...”Publicado no Prev Chronic Dis (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Wong, Brian E, Carmona, Juan J, Fortunato-habib, Mary M, van Aggelen, Helen C, Doty, Alan J, Gross, Brian D
Publicado no Open Forum Infect Dis (2019)
“... retrospective data spanning 18 months (November 2016 to June 2018) from two US-based academic tertiary hospitals...”Publicado no Open Forum Infect Dis (2019)
Obter o texto integral
Obter o texto integral
Artigo
19
Por Nguyen, P L, Martin, N E, Choeurng, V, Palmer-Aronsten, B, Kolisnik, T, Beard, C J, Orio, P F, Nezolosky, M D, Chen, Y-W, Shin, H, Davicioni, E, Feng, F Y
Publicado no Prostate Cancer Prostatic Dis (2017)
“...BACKGROUND: We examined the ability of a biopsy-based 22-marker genomic classifier (GC) to predict...”Publicado no Prostate Cancer Prostatic Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por de Thonel, A, Hazoumé, A, Kochin, V, Isoniemi, K, Jego, G, Fourmaux, E, Hammann, A, Mjahed, H, Filhol, O, Micheau, O, Rocchi, P, Mezger, V, Eriksson, J E, Rangnekar, V M, Garrido, C
Publicado em 2014
“... in prostate cancer cells. The serine/threonine kinase casein kinase 2 (CK2) has a well-reported role...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo